CXCL12 Inhibition Prevents Telomere Shortening and Repression of Telomerase Activity in Both Early and Late Post-menopausal Atherosclerosis via ABCA1 Upregulation
DOI:
https://doi.org/10.7546/CRABS.2023.03.12Keywords:
ABCA1, atherosclerosis, CXCL12/CXCR4, telomere length, vascular senescenceAbstract
Vascular senescence is a key component in the initiation of atherosclerosis and its related cardiovascular disorders. C-X-C Motif Chemokine Ligand 12 (CXCL12), the CXC chemokine receptor 4 (CXCR4) ligand is a chemokine known to promote atherosclerosis. However, the role of telomeres in CXCL12-mediated senescence-induced atherosclerosis remains obscure. This study aimed to unravel the role of CXCL12 and its association with telomeres in the context of menopause-induced arterial senescence and atherosclerosis. Apoe–/– mice underwent bilateral ovariectomy (OVX) to simulate early and late postmenopausal (EPM) conditions (1 and 5 weeks post-OVX, respectively). POL5551, a selective CXCR4 antagonist, was administered as a continuous infusion (30 mg/kg/day in PBS) using a subcutaneously implanted osmotic minipump for two weeks. ATP binding cassette transporter A1 (ABCA1), a cholesterol efflux regulator was significantly downmodulated (p < 0.05), while NOD-, LRR- and pyrin domain-containing protein 3 (NLR) family pyrin domain containing 3 (NLRP3), inducible nitric oxide synthase (iNOS) and the inflammatory mediators were considerably enhanced (p < 0.05) in both EPM and LPM mice groups. Notably, atherosclerosis was more prominent in the EPM than in the LPM mice. However, POL5551 treatment effectively ameliorated the reduced ABCA1 expression and the increased inflammatory response. Hence, we propose that inhibition of CXCL12 proffers robust anti-senescent and anti-atherosclerotic effects.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Proceedings of the Bulgarian Academy of SciencesCopyright (c) 2022 Proceedings of the Bulgarian Academy of Sciences
Copyright is subject to the protection of the Bulgarian Copyright and Associated Rights Act. The copyright holder of all articles on this site is Proceedings of the Bulgarian Academy of Sciences. If you want to reuse any part of the content, please, contact us.